SynAct Pharma AB · OMXSTO:SYNACT
Quantass ApS bought 20,313 SynAct Pharma AB shares (MAR article 19 notification)
Traded Nov 16, 2026 · Filed Nov 18, 2026 · Read by 6ix Nov 18, 2026
On Nov 16, 2026, Quantass ApS (Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)) bought 20,313 SynAct Pharma AB shares at SEK 14.25 for SEK 289K. Filed Nov 18, 2026 (MAR article 19 notification).
- Bought
- 20,313 shares
- Price
- SEK 14.25
- Value
- SEK 289K
- Role
- Closely associated with Jeppe Øvlesen (Chief Executive Officer (CEO)/Managing Directory)
The register entry
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | SynAct Pharma AB | Buy | 20,313 | SEK 14.25 | Indirect |
Source
View original at Finansinspektionen
Related
- SynAct Pharma AB
- Quantass ApS
- SynAct Pharma AB shareholders
- MAR article 19 notification · Quantass ApS · Sep 7, 2026
- MAR article 19 notification · Quantass ApS · Mar 9, 2026
- MAR article 19 notification · Quantass ApS · Dec 22, 2025
- MAR article 19 notification · TJ Biotech Holding ApS · Sep 7, 2026
- MAR article 19 notification · Anders Kronborg · Mar 10, 2026
- MAR article 19 notification · Mads Liebach Bjerregaard · Mar 9, 2026
- MAR article 19 notification · Boesen Biotech ApS · Mar 6, 2026
- MAR article 19 notification · TJ Biotech Holding ApS · Dec 31, 2025